BioLife Solutions Inc. (BLFS)
24.79
0.44 (1.81%)
At close: Apr 24, 2025, 3:59 PM
24.80
0.04%
After-hours: Apr 24, 2025, 04:05 PM EDT
1.81% (1D)
| Bid | 21.76 |
| Market Cap | 1.18B |
| Revenue (ttm) | 87.2M |
| Net Income (ttm) | -20.18M |
| EPS (ttm) | -0.25 |
| PE Ratio (ttm) | -99.16 |
| Forward PE | 168.85 |
| Analyst | Buy |
| Ask | 29.89 |
| Volume | 351,330 |
| Avg. Volume (20D) | 438,100 |
| Open | 24.54 |
| Previous Close | 24.35 |
| Day's Range | 23.88 - 24.91 |
| 52-Week Range | 16.10 - 29.55 |
| Beta | 1.93 |
About BLFS
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are form...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Nov 22, 1989
Employees 159
Stock Exchange NASDAQ
Ticker Symbol BLFS
Website https://www.biolifesolutions.com
Analyst Forecast
According to 7 analyst ratings, the average rating for BLFS stock is "Buy." The 12-month stock price forecast is $31, which is an increase of 25.05% from the latest price.
Stock ForecastsNext Earnings Release
BioLife Solutions Inc. is scheduled to release its earnings on May 8, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
11 months ago
+5.73%
BioLife Solutions shares are trading higher after ...
Unlock content with
Pro Subscription
